Delivery Order SPE2DB20D3101-SPE2DB23FRCH0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,147.05 firm fixed-price delivery order is for the supply of 60 tablets of 450 mg Valganciclovir, a medication used to treat cytomegalovirus infections. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $4,048.61 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Valganciclovir 450 mg tablets in unit dose packaging of 20s. This is a firm fixed price, competitively awarded contract with no set-aside designation and a performance location in Conshohocken, Pennsylvania. The delivery order is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- This federal contract award is for the delivery of 60 tablets of 450 mg valganciclovir to the Defense Logistics Agency (DLA). The contract, valued at $8,903.50, was awarded on December 2, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a performance period ending on December 3, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,902.03 firm-fixed-price delivery order is for the supply of 88 ml of valganciclovir hydrochloride 50 mg/ml, a medication used to treat cytomegalovirus infections. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $4,120.32 to AmerisourceBergen Drug Corp for the supply of Valganciclovir HCL 50 mg/ml in an 88ml formulation. This is a firm fixed price, non-set-aside delivery order with a completion date of September 11, 2025, issued on September 10, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,565.20 firm-fixed-price delivery order is for the supply of Valacyclovir HCL 1 gram tablets. The award was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,615.94, is for the supply of 4,563,021,749 units of Valacyclovir 1GM tablets. The contract has an ultimate completion date of January 5, 2024 and is a Firm Fixed Price contract type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This contract is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $2,082.34. The contract provides for the delivery of Valacyclovir HCL 1 gram tablets, a prescription medication, to support federal medical supply requirements. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award, indicating open competition. The delivery order is part of a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a range of pharmaceutical products and medical supplies. The $3,474.00 delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,893.21 firm fixed-price contract is for the delivery of 90-count tablets of the antiviral medication valacyclovir hydrochloride 1 gram. The contract has a completion date of July 14, 2025 and is not set-aside for any specific business category. Amerisourcebergen Drug Corp holds a larger...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRCH0Delivery Order
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,349.44 firm fixed-price contract is for the delivery of 4559897831 - Valganciclovir 450 mg tablets. The award is not set aside for any particular business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies supporting military and veteran healthcare programs globally. This delivery order is issued against that larger IDC contract vehicle. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 2/9/23 |